A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
NCT07336446
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
AZD9750
DRUG:
AZD5305
Sponsor
AstraZeneca